Cardio Diagnostics Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Cardio Diagnostics Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 1,461% in 3 years, but profit fell: $13,241 less profit per $100 of extra sales. Lower than almost all Healthcare companies in United States.
- Shareholder Slice Ratio: Share count rose 476% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 86% of Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 87% of its market value (net cash). Higher than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-10.1×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 51% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$13,241Sales grew 1,461% in 3 years, but profit fell: $13,241 less profit per $100 of extra sales.
Lower than almost all Healthcare companies in United States.
Asset Productivity Ratio
+1461% / +24%In 3 years sales changed by +1461% while total assets changed by +24%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-21.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 56% of Healthcare companies in United States.
Cash Cushion Ratio
+87%Cash, after subtracting all debt, equals 87% of its market value (net cash).
Higher than 86% of Healthcare companies in United States.
Tangible Assets Ratio
89%Of every $100 the company owns, $89 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 60% of Healthcare companies in United States.
Tangible Net Worth Ratio
87%Of every $100 of net worth, $87 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 69% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Cardio Diagnostics Holdings, Inc. made a loss over the last year. Cardio Diagnostics Holdings, Inc. owes $0.06 for every $1 it owns. Cardio Diagnostics Holdings, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCardio Diagnostics Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.67The share price is 0.67 times Cardio Diagnostics Holdings, Inc.'s book value per share, lower than 87% of Healthcare companies in United States.
Market cap
$5 MThe total market value of all of Cardio Diagnostics Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 93% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$7 MWhat Cardio Diagnostics Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.51Net worth divided by the number of shares. The share price of $1.69 is 0.7 times this, which is the P/B above.
Return on equity (ROE)
-75.4%Cardio Diagnostics Holdings, Inc. lost 75.4% of its shareholders' money over the last year, lower than 63% of Healthcare companies in United States.
Owes vs Owns
0.06×Cardio Diagnostics Holdings, Inc. owes $0.06 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Dividend yield
NoneCardio Diagnostics Holdings, Inc. does not currently pay a dividend.
Revenue growth
-58%Revenue fell 58% in the year to Dec 2025, and grew 150% a year on average over 3 years.
Profit growth
LossCardio Diagnostics Holdings, Inc. made a loss in each of the last two years.
Profit margin
-43832.5%Cardio Diagnostics Holdings, Inc. lost $43832 for every $100 of revenue.
Interest cover
Not coveredCardio Diagnostics Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashCardio Diagnostics Holdings, Inc. held $4 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Cardio Diagnostics Holdings, Inc.: $5 M ÷ $7 M (30 Jun 2026) = 0.7.
What is Cardio Diagnostics Holdings, Inc.'s return on equity?
Cardio Diagnostics Holdings, Inc. lost 75.4% of its shareholders' money over the last year, lower than 63% of Healthcare companies in United States.
How much does Cardio Diagnostics Holdings, Inc. owe compared with what it owns?
Cardio Diagnostics Holdings, Inc. owes $0.06 for every $1 it owns (low), lower than 93% of Healthcare companies in United States.
Does Cardio Diagnostics Holdings, Inc. pay a dividend?
No. Cardio Diagnostics Holdings, Inc. does not currently pay a dividend.
Is Cardio Diagnostics Holdings, Inc.'s revenue growing?
Revenue fell 58% in the year to Dec 2025, and grew 150% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.